Biotech

Cannabis Science Inc (OTCMKTS:CBIS) shares rose 9.77% on Friday to $0.0657 and retreated 0.61% to $0.0653 in after-hours trading. Share prices have been trading in a 52-week range of $0.01 to $0.08. The company has a market cap of $150.54 million at 2.31 billion shares outstanding. Cannabis Science Inc is a...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Computer Programs & Systems Inc. (NASDAQ:CPSI) reported that Stadium Capital Management has picked up 1,379,151 of common stock as of 2017-01-06. The acquisition brings the aggregate amount owned by Stadium Capital Management to a total...

Conestoga has been busy in the New Year, with investments across the biotechnology sector, all reported today. Here at Small Cap Exclusive, of course, we're keeping up with things, however busy they may be. Here's what the latest filing has revealed. In a just published Form 13, filed with the...

The biotech sector struggled throughout the latter half of 2016, as markets priced in expectations of a Democratic term in the White House, and what this might mean for drug pricing. Forced lower pricing would reduce big name investment, and this could hurt the smaller companies' potential to expand...

Barry Honig is one of the biotech space's most renowned entrepreneurs and investors. Along with his compatriot, Dr. Phillip Frost, he has been responsible for some of the big name successes in the sector. Many investors like to piggyback his positions, so here's one he just announced. In a just...